Mavacoxib (Standard)
Mavacoxib (Standard) is the analytical standard of Mavacoxib. This product is intended for research and analytical applications. Mavacoxib is a selective, oral long-acting cyclooxygenase-2 (COX-2) inhibitor and a long-acting non-steroidal anti-inflammatory drug (NSAID) . Mavacoxib is used to treat pain and inflammation associated with degenerative joint disease in dogs[1].
Product Specifications
CAS Number
170569-88-7
UNSPSC
12352100
Target
COX; Reference Standards
Related Pathways
Immunology/Inflammation; Others
Field of Research
Inflammation/Immunology
Smiles
O=S(C1=CC=C(N2N=C(C(F)(F)F)C=C2C3=CC=C(F)C=C3)C=C1)(N)=O
Molecular Formula
C16H11F4N3O2S
Molecular Weight
385.34
References & Citations
[1]Hurst EA, et al. The selective cyclooxygenase-2 inhibitor mavacoxib (Trocoxil) exerts anti-tumour effects in vitro independent of cyclooxygenase-2 expression levels. Vet Comp Oncol. 2019 Jun;17 (2) :194-207.|[2]Cox SR, et al. Population pharmacokinetics of mavacoxib in osteoarthritic dogs. J Vet Pharmacol Ther. 2011 Feb;34 (1) :1-11.
Shipping Conditions
Room temperature
Scientific Category
Reference Standards
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
VAng-Cr5018-50gEcoli 50 µg (E. coli)
Recombinant Klebsiella Pneumoniae kpnIM Protein (aa 1-417)
Sign In for Pricing
View Details 
NBP2-36277AF647 0.1 mL
Mouse Monoclonal CEACAM1/CD66a Antibody (B3-17) [Alexa Fluor 647]
Sign In for Pricing
View Details